Allostery Investments LP Tango Therapeutics, Inc. Transaction History
Allostery Investments LP
- $7.85 Billion
- Q2 2025
A detailed history of Allostery Investments LP transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 40,000 shares of TNGX stock, worth $307,600. This represents 2.61% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$307,600% of portfolio
2.61%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
117MCall Options Held
245KPut Options Held
18.9K-
Trv Gp Iv, LLC Boston, MA16.9MShares$130 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$82.6 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$81.8 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$70.4 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$46.4 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $677M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...